David J. Marguglio, SVP and Chief Business Officer at Adamis Pharmaceuticals Corp (ADMP), sold 8,735 shares at $1.77 ($15K) on 2019-05-20, disclosed to the SEC on 2019-05-22.
Scheduled sale ($15k) by SVP and Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADMP | SELL | 2020-11-24 | $14K | — | Filing → |
| ADMP | SELL | 2020-11-20 | $3K | — | Filing → |
| ADMP | SELL | 2020-10-01 | $16K | — | Filing → |